Phylonix is using zebrafish to assess compound safety, toxicity and efficacy. We provide services to the following industries: Pharmaceutical, Biotechnology, Environmental, Industrial Product Safety, Agrochemical, and Nutraceuticals.
Services
ZETAX™ Teratogenicity Assay - In a recent study performed for Bristol-Myers Squibb, zebrafish were treated with 12 reference compounds from 6-12 hours. The assay was ranked good for specificity and excellent for sensitivity.
Read moreCustom Studies
Results in zebrafish show a striking correlation to results in mammals. We design specialized assays and disease models.
Read moreNews
NIH Grants Phylonix Phase II SBIR to Develop High-Throughput In vivo Zebrafish Assays for Assessing Cytochrome P450 Drug Metabolism and Safety - Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,250,369 Phase II Small Business...
Read more